Accredited Continuing Education
Before completing the evaluation, please participate in SCAI SHOCK 2022 and related activities.
- Sign in with your SCAI credentials.
- Complete evaluations for the activities you attended.
- Claim appropriate credit.
- Your certificate will automatically be delivered to your email, and you will also find a copy on the left-side navigation under "Transcript."
Use the link above to evaluate the meeting and activities to claim CME, ABIM-MOC, Nurse CE, ASRT Category A Credits, or a Certificate of Participation. Note that the Certificate of Participation can also be used as a Certificate of Completion.
If you are claiming ASRT Category A Credits, please complete the SCAI 2022 SHOCK evaluation and then email firstname.lastname@example.org to receive your certificate.
Due to reporting deadlines established by the American Board of Internal Medicine, MOC points will not be available after December 31, 2022.
The Society for Cardiovascular Angiography and Interventions is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Society for Cardiovascular Angiography and Interventions designates this live activity for a maximum of 11.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 11.25 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Nurses and Radiology Technologists
This educational activity is pending approval by the Cardiovascular & Pulmonary Continuing Education (CaPCE) for up to 11 contact hours of accredited education. Provider approved by the California Board of Registered Nursing, Provider Number CEP1531.
Pick up your conference badge, attend the conference, and complete the post-activity evaluation to obtain credit.
Acknowledgment of Commercial Support
This activity is supported by an unrestricted educational grant from Abiomed. SCAI has received in-kind support in the form of medical devices from Abbott, Abiomed, Asahi, B. Braun, Boston Scientific, Cook, Cordis, FUJIFILM Sonosite, Inc., Medtronic, Philips, Teleflex, Terumo, and W. L. Gore & Associates.
Individuals in control of content reported the following relevant financial relationships with ineligible companies during the content development process for this activity. All relevant financial relationships will be mitigated before the start of the activity. A complete list of disclosures will be available in the conference app.
Alexander Truesdell: Abiomed - Stocks, Consulting, Speaker. Shockwave – Stocks
Perwaiz Meraj: Abiomed and Cardiovascular Systems, Inc. - Advisory Board
M. Baber Basir: Abiomed - Principal Investigator, Consulting. ZOLL - Principal Investigator, Consulting. Abbott Vascular, Chiesi, Cardiovascular Systems, Inc., Saranaz – Consulting.
David Cox: No financial relationships with ineligible companies.
Carolyn Rosner, RN: No financial relationships with ineligible companies.
SCAI's Independent Content
As a provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME), it is the Society's policy to ensure balance, independence, objectivity, and scientific rigor in all its activities.
SCAI activities are developed by the SCAI Planners prior to and independent of commercial support. As planners had relevant financial relationships, the agenda was peer reviewed by a member with no relevant financial relationships.
Mitigation of Relevant Financial Relationships
All participating planners, reviewers, faculty, and staff are required to disclose to SCAI all financial relationships with ineligible companies. SCAI identifies relevant financial relationships and mitigates them before the activity begins.
Content Validation Statement
SCAI accepts the following Content Validation Statements and expects all persons involved in its professional education activities to abide by these statements for clinical care recommendations. All clinical and pharmacological recommendations are based on evidence accepted within the medical profession as adequate jurisdiction for their indications and contradictions in patient care. All research referenced to support or justify patient care recommendations conforms to accepted standards of experimental design, data collection and analysis.
SCAI does not promote recommendations, treatment, or manners of practicing medicine that are not within the definition of accredited continuing education or known to have risks or dangers that outweigh the benefits or known to be ineffective in the treatment of patients.
SCAI actively promotes improvements in health care and NOT proprietary interests of an ineligible company.
SCAI's educational content is free of marketing or sales of products or services. Faculty will not actively promote or sell products or services that serve their professional or financial interests during accredited education.
SCAI encourages faculty to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration (FDA), at first mention and where appropriate in the content.